Minimally Invasive Glaucoma Surgery (MIGS) has revolutionized glaucoma treatment by providing a less invasive and safer option compared to traditional surgical methods. These procedures aim to lower intraocular pressure by enhancing the drainage of aqueous humor through small, precise incisions. Typically involving the use of micro-stents or tiny shunts, MIGS improves fluid outflow from the eye's anterior chamber, reducing stress on the optic nerve. The minimally invasive nature of MIGS results in faster recovery, fewer complications, and less postoperative pain. Suited for patients with mild to moderate glaucoma, MIGS is gaining popularity as a preferred treatment, offering significant benefits in maintaining vision and enhancing overall quality of life.
Object: Primary Open-Angle Glaucoma (POAG) remains a leading cause of irreversible blindness, with Minimally Invasive Glaucoma Surgery (MIGS) emerging as a pivotal strategy for early-stage…
Introduction: In this review, an analysis of the outcomes of Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) was done in patients with Primary Open-Angle Glaucoma (POAG), with outcomes in one…
Introduction: In this review, an analysis of the outcomes of Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) was done in patients with Primary Open-Angle Glaucoma (POAG), with outcomes in one…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Minimally Invasive Glaucoma Surgery work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Minimally Invasive Glaucoma Surgery research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Minimally Invasive Glaucoma Surgery track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Minimally Invasive Glaucoma Surgery. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Minimally Invasive Glaucoma Surgery are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Minimally Invasive Glaucoma Surgery track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
